We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

30 hedge funds and large institutions have $4.16M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

6% less funds holding

Funds holding: 3230 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

57% less capital invested

Capital invested by funds: $9.69M → $4.16M (-$5.53M)

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
3
Closed
2
Calls
$2.64M
Puts
Net Calls
+$2.64M
Net Calls Change
+$83K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Saba Capital Management
New York
$347
HHGC
27
Hunting Hill Global Capital
New York
$278
UBS Group
28
UBS Group
Switzerland
$259 -$30 -1,020 -6%
WAM
29
Wolverine Asset Management
Illinois
$168
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
-$1.9K -38,060 Closed
OMC
31
Old Mission Capital
Illinois
-$854 -17,085 Closed
FTUS
32
Flow Traders U.S.
New York
-$27 -937 -7%

VHAQ.WS Hedge Fund Activity: Q1 2023 in Review

30 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q1 2023, worth a combined $4.16M — down 57% from $9.69M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VHAQ.WS and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 6 added.

The largest buyer was Radcliffe Capital Management, adding an estimated $14.6K. The largest seller was K2 Principal Fund, cutting an estimated $15.1K.

  • 30 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q1 2023, down from 32 in Q4 2022.
  • Funds reported $4.16M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q1 2023, down 57% quarter-over-quarter.
  • 1 fund opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q1 2023 and 2 closed out, a net change of -1 holder.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q1 2023 was Radcliffe Capital Management, an estimated $14.6K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q1 2023 was K2 Principal Fund, an estimated $15.1K sold.

Based on aggregated 13F filings for Q1 2023.